GLI3
Transcriptional activator GLI3
Also known as: ACLS, GCPS, GLI3_HUMAN, PAP-A, PAPA, PAPA1, PAPB, PHS, PPDIV
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P10071
- Gene
- GLI3
- Ensembl
- ENSG00000106571
- Chromosome
- 7
- Canonical length
- 1580 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli,Vesicles
OverviewNCBI Gene
This gene encodes a protein which belongs to the C2H2-type zinc finger proteins subclass of the Gli family. They are characterized as DNA-binding transcription factors and are mediators of Sonic hedgehog (Shh) signaling. The protein encoded by this gene localizes in the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. Mutations in this gene have been associated with several diseases, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, and postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1580 residues, UniProt reviewed canonical sequence.
>P10071|GLI3
1 MEAQSHSSTT TEKKKVENSI VKCSTRTDVS EKAVASSTTS NEDESPGQTY HRERRNAITM
61 QPQNVQGLSK VSEEPSTSSD ERASLIKKEI HGSLPHVAEP SVPYRGTVFA MDPRNGYMEP
121 HYHPPHLFPA FHPPVPIDAR HHEGRYHYDP SPIPPLHMTS ALSSSPTYPD LPFIRISPHR
181 NPTAASESPF SPPHPYINPY MDYIRSLHSS PSLSMISATR GLSPTDAPHA GVSPAEYYHQ
241 MALLTGQRSP YADIIPSAAT AGTGAIHMEY LHAMDSTRFS SPRLSARPSR KRTLSISPLS
301 DHSFDLQTMI RTSPNSLVTI LNNSRSSSSA SGSYGHLSAS AISPALSFTY SSAPVSLHMH
361 QQILSRQQSL GSAFGHSPPL IHPAPTFPTQ RPIPGIPTVL NPVQVSSGPS ESSQNKPTSE
421 SAVSSTGDPM HNKRSKIKPD EDLPSPGARG QQEQPEGTTL VKEEGDKDES KQEPEVIYET
481 NCHWEGCARE FDTQEQLVHH INNDHIHGEK KEFVCRWLDC SREQKPFKAQ YMLVVHMRRH
541 TGEKPHKCTF EGCTKAYSRL ENLKTHLRSH TGEKPYVCEH EGCNKAFSNA SDRAKHQNRT
601 HSNEKPYVCK IPGCTKRYTD PSSLRKHVKT VHGPEAHVTK KQRGDIHPRP PPPRDSGSHS
661 QSRSPGRPTQ GALGEQQDLS NTTSKREECL QVKTVKAEKP MTSQPSPGGQ SSCSSQQSPI
721 SNYSNSGLEL PLTDGGSIGD LSAIDETPIM DSTISTATTA LALQARRNPA GTKWMEHVKL
781 ERLKQVNGMF PRLNPILPPK APAVSPLIGN GTQSNNTCSL GGPMTLLPGR SDLSGVDVTM
841 LNMLNRRDSS ASTISSAYLS SRRSSGISPC FSSRRSSEAS QAEGRPQNVS VADSYDPIST
901 DASRRSSEAS QSDGLPSLLS LTPAQQYRLK AKYAAATGGP PPTPLPNMER MSLKTRLALL
961 GDALEPGVAL PPVHAPRRCS DGGAHGYGRR HLQPHDAPGH GVRRASDPVR TGSEGLALPR
1021 VPRFSSLSSC NPPAMATSAE KRSLVLQNYT RPEGGQSRNF HSSPCPPSIT ENVTLESLTM
1081 DADANLNDED FLPDDVVQYL NSQNQAGYEQ HFPSALPDDS KVPHGPGDFD APGLPDSHAG
1141 QQFHALEQPC PEGSKTDLPI QWNEVSSGSA DLSSSKLKCG PRPAVPQTRA FGFCNGMVVH
1201 PQNPLRSGPA GGYQTLGENS NPYGGPEHLM LHNSPGSGTS GNAFHEQPCK APQYGNCLNR
1261 QPVAPGALDG ACGAGIQASK LKSTPMQGSG GQLNFGLPVA PNESAGSMVN GMQNQDPVGQ
1321 GYLAHQLLGD SMQHPGAGRP GQQMLGQISA TSHINIYQGP ESCLPGAHGM GSQPSSLAVV
1381 RGYQPCASFG GSRRQAMPRD SLALQSGQLS DTSQTCRVNG IKMEMKGQPH PLCSNLQNYS
1441 GQFYDQTVGF SQQDTKAGSF SISDASCLLQ GTSAKNSELL SPGANQVTST VDSLDSHDLE
1501 GVQIDFDAII DDGDHSSLMS GALSPSIIQN LSHSSSRLTT PRASLPFPAL SMSTTNMAIG
1561 DMSSLLTSLA EESKFLAVMQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GLI3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.64
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- endometrium: 13 nTPM
- colon: 12 nTPM
- placenta: 11 nTPM
- ovary: 11 nTPM
- smooth muscle: 10 nTPM
- skin: 8.9 nTPM
Single-cell type
- astrocytes: 474 nCPM
- fibro-adipogenic progenitors: 436 nCPM
- syncytiotrophoblasts: 332 nCPM
- mesothelial cells: 316 nCPM
- pituicytes/fscs: 274 nCPM
- medullary thymic epithelial cells: 204 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 41 nTPM
- midbrain: 32 nTPM
- amygdala: 29 nTPM
- basal ganglia: 28 nTPM
- hippocampal formation: 23 nTPM
- cerebral cortex: 22 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GLI3.
Disease | AllUniProt
Conditions GLI3 is implicated in, by any mechanism.
- Greig cephalo-poly-syndactyly syndrome (GCPS) MIM:175700
- Pallister-Hall syndrome (PHS) MIM:146510
- Polydactyly, postaxial A1 (PAPA1) MIM:174200
- Polydactyly, postaxial B (PAPB) MIM:174200
- Polydactyly, preaxial 4 (PPD4) MIM:174700
Disease | GeneticClinVar
204 pathogenic / likely-pathogenic of 1,517 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Greig cephalopolysyndactyly syndrome
- Pallister-Hall syndrome
- GLI3-related disorder
- Polydactyly, postaxial, type A1
- Polysyndactyly 4
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.52
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- alpha-beta T cell differentiation
- anterior/posterior pattern specification
- artery development
- axon guidance
- branching involved in ureteric bud morphogenesis
- camera-type eye morphogenesis
- cell differentiation involved in kidney development
- chondrocyte differentiation
- developmental growth
- embryonic digestive tract development
- embryonic digestive tract morphogenesis
- embryonic digit morphogenesis
- embryonic neurocranium morphogenesis
- forebrain dorsal/ventral pattern formation
- forebrain radial glial cell differentiation
- frontal suture morphogenesis
- heart development
- hindgut morphogenesis
- hippocampus development
- in utero embryonic development
- larynx morphogenesis
- layer formation in cerebral cortex
- limb morphogenesis
- lung development
- melanocyte differentiation
- metanephros development
- negative regulation of alpha-beta T cell differentiation
- negative regulation of apoptotic process
- negative regulation of canonical Wnt signaling pathway
- negative regulation of chondrocyte differentiation
- negative regulation of DNA-templated transcription
- negative regulation of neuron differentiation
- negative regulation of smoothened signaling pathway
- negative regulation of stem cell proliferation
- negative regulation of transcription by RNA polymerase II
- negative thymic T cell selection
- neuroblast proliferation
- nose morphogenesis
- odontogenesis of dentin-containing tooth
- oligodendrocyte differentiation
- optic nerve morphogenesis
- osteoblast differentiation
- positive regulation of alpha-beta T cell differentiation
- positive regulation of chondrocyte differentiation
- positive regulation of DNA-templated transcription
- positive regulation of neuroblast proliferation
- positive regulation of osteoblast differentiation
- positive regulation of protein import into nucleus
- positive regulation of transcription by RNA polymerase II
- protein import into nucleus
- protein processing
- proximal/distal pattern formation
- regulation of bone development
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- roof of mouth development
- smoothened signaling pathway
- smoothened signaling pathway involved in dorsal/ventral neural tube patterning
- smoothened signaling pathway involved in spinal cord motor neuron cell fate specification
- smoothened signaling pathway involved in ventral spinal cord interneuron specification
- stem cell proliferation
- T cell differentiation in thymus
- thymocyte apoptotic process
- tongue development
- vocalization behavior
- anterior semicircular canal development
- lambdoid suture morphogenesis
- lateral ganglionic eminence cell proliferation
- lateral semicircular canal development
- mammary gland specification
- sagittal suture morphogenesis
Molecular functions
- beta-catenin binding
- chromatin binding
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- histone acetyltransferase binding
- histone deacetylase binding
- mediator complex binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GLI3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GLI3 as an antibody target. Whether an autoantibody or antibody against GLI3 could matter depends on whether native GLI3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GLI3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GLI3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...